Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
12/2009
12/02/2009CN101591308A Diacylhydrazine derivatives containing 1,2,3-thiadiazole active group and preparation method and application thereof
12/02/2009CN101591307A Di(1,2,3-thiadiazole-5-formic acid) and preparation method and application thereof
12/02/2009CN101591295A Water-soluble benzopyrazolyl quaternary ammonium salt, preparation method thereof and application thereof
12/02/2009CN101591285A Propionamides compound and usage thereof
12/02/2009CN100564358C Method for making 4-(3,4-dichlorophenoxy)piperidine
12/02/2009CN100564344C 2- and 2,5-substituted phenylketo-enols
12/01/2009US7626037 Thiazolidin-4-one derivatives
12/01/2009US7626030 Compounds and methods of use
12/01/2009US7625937 1H-benzo[F]indazol-5-YL derivatives as selective glucocorticoid receptor modulators
12/01/2009US7625934 Metalloproteinase inhibitors
12/01/2009US7625932 Pyrrole and pyrazole derivatives as potentiators of glutamate receptors
12/01/2009US7625921 Bridged ring compounds based on nitrogen-containing rings such as 5,10-dihydro-5,10-ethanobenzo(g)quinoline; treating obesity, diabetes and inflammatory or immune associated diseases; nuclear factor kappa beta (NF-KB)
12/01/2009US7625917 S-o-(phenylaminocarbonyl)phenyl-substituted, especially with a quaternary onium group; enhanced antiviral activity and better reactivity with zinc finger moieties, particularly, the zinc finger on HIV-1's NCp7 nucleocapsid protein
12/01/2009US7625914 2(S)-Ethoxy-3-{4-[2-(3-heptyl-1-methylureido)thiazol-4-yl]phenyl}propanoic acid; dermatology, and cardiovascular diseases, immune diseases, lipid metabolism diseases; veterinary medicine
12/01/2009US7625913 Inhibitors of glycogen synthase kinase-3 (gsk-3) and aurora-2, both serine/threonine protein kinases; for treating diseases such as cancer, diabetes and alzheimer's disease
12/01/2009US7625909 N-{3-[2-(2-Fluoro-4-methoxyphenyl)-ethyl]-4-oxo-3,4-dihydroquinazolin-7yl}-N-indan-2-yl-3,5-dimethylpiperazine-1-carboxamidine; melanocortin-4 receptor agonists; diabetes
12/01/2009US7625908 Antiproliferative agent in the prevention or treatment of tumors which are sensitive to inhibition of EGF and erbB receptor tyrosine kinases;1-({4-[(3-chloro-2-fluorophenyl)amino]-7-methoxyquinazolin-6-yl}methyl)-L-prolinamide
12/01/2009US7625889 Substituted bis aryl and heteroaryl compounds as selective 5HT2A antagonists
12/01/2009CA2264556C Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
11/2009
11/26/2009WO2009143354A2 Insulated film use in a mems device
11/26/2009WO2009143049A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009WO2009142969A1 Therapeutic lactams
11/26/2009WO2009142967A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009WO2009142321A1 Novel thiophenediamine derivative having urea structure
11/26/2009WO2009141782A1 Tetrahydroisoquinolines as antimalarial agents
11/26/2009WO2009141412A1 1,6-disubstituted 3-azabicyclo [3.1.0] hexane derivatives for use as triple reuptake inhibitors
11/26/2009WO2009141274A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides
11/26/2009WO2009115557A3 Fungicide hydroximoyl-tetrazole derivatives
11/26/2009US20090292119 Methods for synthesizing benzothiazepine compounds
11/26/2009US20090291970 Substituted Aminoethers for the Treatment of Alzheimer's Disease
11/26/2009US20090291969 Fungicide hydroximoyl-tetrazole derivatives
11/26/2009US20090291963 Substituted indoles
11/26/2009US20090291952 Modulators of pharmacokinetic properties of therapeutics
11/26/2009US20090291949 Substitute isoquinolines useful in the treatment of diseases such as cancer and atherosclerosis
11/26/2009US20090291940 Aminopyrrolidine compound
11/26/2009US20090291936 Oxime derivative and preparations thereof
11/26/2009US20090291152 Dibenzothiazepine derivatives
11/26/2009CA2724474A1 Therapeutic prostaglandin compounds used as ocular hypotensive agents
11/26/2009CA2724467A1 Therapeutic lactams
11/26/2009CA2724426A1 Bicyclic heterocycle derivatives and use thereof as gpr119 modulators
11/26/2009CA2724357A1 Novel thiophenediamine derivative having urea structure
11/26/2009CA2723612A1 Tetrahydroisoquinolines as antimalarial agents
11/26/2009CA2723424A1 Intestinal alkaline phosphatase modulators and uses thereof
11/25/2009EP2123644A1 Benzoxazepine derivatives and use thereof
11/25/2009EP2121674A1 Processes and intermediates for preparing a macrocyclic protease inhibitor of hcv
11/25/2009EP2121659A1 Modulators of cb1 receptors
11/25/2009EP2121652A1 4-imidazolyl-1,2,3,4-tetrahydroquinoline derivatives and their use as aldosterone/11-beta-hydroxylase inhibitors
11/25/2009EP2121648A2 S1p receptor modulating compounds and use thereof
11/25/2009EP2121617A1 Cb1 receptor modulators
11/25/2009EP2121608A1 Dihydropyridine derivatives useful as protein kinase inhibitors
11/25/2009EP2120580A2 Compositions and methods for the treatment of metabolic disorders
11/25/2009EP1848694B1 Heterocyclic substituted phenyl methanones as inhibitors of the glycine transporter 1
11/25/2009EP1482932B1 N3 alkylated benzimidazole derivatives as mek inhibitors
11/25/2009EP1242385B1 Cytokine, especially tnf-alpha, inhibitors
11/25/2009EP1144405B1 Triazole compounds with dopamine-d3-receptor affinity
11/25/2009EP0931060B1 Substituted n- (aminoiminomethyl or aminomethyl)phenyl propyl amides
11/25/2009CN101589040A Polymorphic forms of a macrocyclic inhibitor of HCV
11/25/2009CN101589039A Azacycloalkane derivatives as inhibitors of stearoyl-coenzyme A delta-9 desaturase
11/25/2009CN101589037A Heteromonocyclic compound and use thereof
11/25/2009CN101589030A 3-amino-1,2-benzisothiazole compounds for combating animal pest ii
11/25/2009CN101585819A Preparation method for 1,2,3-thiadiazole thioacetanilides derivatives
11/25/2009CN101584694A Peptide deformylase inhibitor containing 2, 5-dihydropyrrole and synthesizing method
11/25/2009CN101584691A Compounds effecting glucokinase
11/25/2009CN101584337A 1, 5-disubstituted hexahydro triazine pesticide and preparation method thereof
11/25/2009CN100562518C Novel arylethene-sulfonamides compounds
11/25/2009CN100562513C Benzamide derivative or salt thereof
11/24/2009US7622592 N-(3,5-dichlorobenzyl)-N'-[2-(1,3-thiazol-4-yl)-1H-benzimidazol-5-yl]urea; androgen receptor (AR) modulators (agonists) in tissue-directed therapy (bone, muscle) while antagonizing the AR in the prostate or uterus; bone disorders; peridontal disease; sarcopenia; atherosclerosis; antiarthritic agents;
11/24/2009US7622579 Hetero isonipecotic modulators of vanilloid VR1 receptor
11/24/2009US7622490 Broadspecturm 2-amino-benzoxazole sulfonamide HIV protease inhibitors
11/24/2009US7622487 Piperidine derivative, process for producing the same, and use
11/24/2009US7622481 Gramnegative and Grampositive bacterial infections; substituted Piperidine derivatives specially optionally substituted pyrido [3,2, -b][1,4] thiazin-yl; 6-({(3R,4S)-3-Fluoro-1-[(R)-2-hydroxy-2-(2-methoxy-quinolin-8-yl)-ethyl]-piperidin-4-ylamino }-methyl)-4H-pyrido[3,2-b][1,4]thiazin-3-one; nontoxic
11/24/2009US7622474 Asulfonyl(urea, thiourea, guanidine, cyanoguanidine) compounds; cardiovascular disorders; thrombosis
11/24/2009US7622464 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists
11/24/2009CA2552786C Crystalline polymorph of a bisulfate salt of a thrombin receptor antagonist
11/24/2009CA2526145C C-glycoside derivatives or salts thereof for use as na+-glucose cotransporter inhibitors
11/24/2009CA2415383C New amidino derivatives and their use as thrombin inhibitors
11/24/2009CA2408144C Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
11/24/2009CA2385882C Tyrosine derivatives
11/19/2009WO2009140624A2 Glucokinase activators
11/19/2009WO2009140475A1 Hepatitis c virus inhibitors
11/19/2009WO2009139373A1 Amide compound
11/19/2009WO2009139361A1 Glucocorticoid receptor agonist composed of 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative having substituted oxy group
11/19/2009WO2009139340A1 Pyrazole compound
11/19/2009WO2009103007A3 Steroid hormone receptor modulator compounds and methods
11/19/2009WO2009094442A3 5-fluoro pyrimidine derivatives as fungicides
11/19/2009WO2009088192A9 Indole and indazole derivatives having a cell-, tissue- and organ-preserving effect
11/19/2009US20090286975 Indole compound
11/19/2009US20090286974 Derivative having ppar agonistic activity
11/19/2009US20090286821 Inhibitors of tyrosine kinases
11/19/2009US20090286800 Glucokinase Activators
11/19/2009US20090286792 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors
11/19/2009US20090286781 Use of Suluble Guanylate Cyclase Acitvators for Treating Acute and Chronic Lung Diseases
11/19/2009US20090286775 Bicyclic Derivatives as P38 Kinase Inhibitors
11/19/2009US20090286772 2-(Phenyl or Heterocyclic)-1H-Phenanthro[9,10-D]Imidazoles
11/19/2009US20090286766 Azolecarboxamide derivative
11/19/2009CA2724232A1 Sulfone compounds which modulate the cb2 receptor
11/19/2009CA2724116A1 Glucokinase activators
11/19/2009CA2724077A1 Amide compound
11/19/2009CA2724055A1 Glucocorticoid receptor agonist comprising 2,2,4-trimethyl-6-phenyl-1,2 -dihydroquinoline derivatives having substituted oxy group
11/18/2009EP2119703A1 Novel indole derivative having inhibitory activity on i b kinase
1 ... 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 ... 628